StorosumJGElferinkAJvan ZwietenBJvan den BrinkWGersonsBPvan StrikRBroekmansAW. Short-term efficacy of tricyclic antidepressants revisited: a meta-analytic study. European Neuropsychopharmacology2001; 11: 173–180
2.
KhanAKhanSBrownWA. Are placebo controls necessary to test new antidepressants and anxiolytics?International Journal of Neuropsychopharmacology2002; 5: 193–197
3.
ThaseMEFriedmanESBermanSRFasiczkaALLisJAHowlandRHSimonsAD. Is cognitive behaviour therapy just a ‘nonspecific’ intervention for depression? A retrospective comparison of consecutive cohorts treated with cognitive behaviour therapy or supportive counselling and pill placebo. Journal of Affective Disorders2000; 57: 63–71
4.
JohnstoneECDeakingJFLawlerPFrithCDStevensMMcPhersonKCrowTJ. The Northwick Park electroconvulsive therapy trial. Lancet1982; 2: 1317–1320
5.
BrughaTSBebbingtonPEMacCarthyEStuartEWykesT. Antidepressants may not assist recovery in practice: a naturalistic prospective study. Acta Psychiatrica Scandinavica1992; 86: 5–11
6.
MaybergHSSilvaJABrannanSKTekellJLMahurinRKMcGinnisSJerabekPA. The functional neuroanatomy of the placebo effects. American Journal of Psychiatry2002; 159: 728–737
7.
LeuchterAFCookIAWitteEAMorganM. Abrams M. Changes in brain function of depressed subjects during treatment with placebo. American Journal of Psychiatry2002; 159: 122–129
8.
PosternakMAMillerI. Untreated short-term course of major depression: a meta-analysis of outcomes from studies using waiting-list control groups. Journal of Affective Disorders2001; 66: 139–146
KaptchukT. The placebo effect in alternative medicine: can the performance of a healing ritual have clinical significance?Annals of Internal Medicine2002; 136: 817–825
11.
McKayDSchareML. The effects of alcohol and alcohol expectancies on subjective reports and physiological reactivity: a meta-analysis. Addictive Behaviors1999; 24: 633–647
12.
MitchellSHLaurentCLde WitH. Interaction of expectancy and the pharmacological effects of d-amphetamine: subjective effects and self-administration. Psychopharmacology1996; 125: 371–378
13.
McPhersonKBrittonARWennbergJE. Are randomised controlled trials controlled? Patient preferences and unblind trails. Journal of the Royal Society of Medicine1997; 90: 652–656
14.
SotskySMGlassDRSheaMTPilkonisPACollinsJFElkingIPatient predictors of response to psychotherapy and pharmacotherapy: findings in the NIMH. Treatment of Depression Collaborative Research Program. American. Journal of Psychiatry1991; 148: 997–1008
15.
GallagherEJViscoliCMHorwitzRI. The relationship of treatment adherence to the risk of death after myocardial infraction in women. Journal of the American Medical Assocation1990; 270: 742–744
16.
CrowRGageHHampsonSHartJKimberAThomasH. The role of expectancies in the placebo effect and their use in the delivery of health care: a systematic review. Health Technology Assessment1998; 3: 3
Di BlasiZHarknessEErnstEGeorgionAKeijenenJ. Influence of context effects on health outcomes: a systematic review. Lancet2001; 357: 757–762
19.
PaykelESPriestRG. Recognition and management of depression in general practice: consensus statement. BMJ1992; 305: 1198–1202
20.
BacharE. Psychotherapy — an active agent: assessing the effectiveness of psychotherapy and its curative factors. Israel Journal of Psychiatry and Related Sciences1998; 35: 128–135
21.
CarlozziAFBullKSSteinLBRoyKBarnesL. Empathy and practice: a survey of psychologists and counsellors. Journal of Psychology2002; 136: 161–170
22.
JenkinsVFallowfieldL. Can communication skills training alter physicians’ beliefs and behaviour in clinics?Journal of Clinical Oncology2002; 20: 765–769
23.
ThomasKB. General practice consultations: is there any point in being positive?BMJ1987; 294: 1200–1202
24.
WheatleyD. Influence of doctors’ and patients’ attitudes in the treatment of neurotic illness. Lancet1967; 2: 1133–1135
25.
CruzMPincusHA. Research on the influence that communication in psychiatric encounters has on treatment. Psychiatric Services2002; 53: 1253–1265
26.
HorvathAOLuborkskyL. The role of the therapeutic alliance in psychotherapy. Journal of Consulting and Clinical Psychology1993; 61: 561–575
27.
FrankAGundersonJG. The roles of the therapeutic alliance in the treatment of schizophrenia. Archives of General Psychiatry1990; 47: 228–236
28.
WeissMGastonLPropstAWisebordSZichermanV. The role of the alliance in the pharmacological treatment of depression. Journal of Clinical Psychiatry1997; 58: 196–204
29.
StewartMA. Effective physician-patient communication and health outcomes: a review. Canadian Medical Association Journal1995; 152: 1423–1433
30.
StarfieldBWrayCHessKGrossRBirkPSD'LugoffBC. The influence of patient-practitioner agreement on outcome of care. American Journal of Public Health1981; 71: 127–131
31.
AndrewsG. Placebo response in depression: bane of research, boon to therapy. British Journal of Psychiatry2001; 178: 192–194
32.
JohnstoneECCrowTJFrithCDCarneyMWPriceJS. Mechanism of the antipsychotic effect in the treatment of acute schizophrenia. Lancet1978; 1: 848–851
33.
SchapiraKMcClellandHAGriffithsNRNewellDJ. A study on the effects of tablet colour on the treatment of anxiety states. BMJ1970; 1: 446–469
34.
BranthwaiteACooperP. Analgesic effects of branding in treatment of headache. BMJ1981; 282: 1576–1578
35.
De CraenAJMoermanDEHeisterkampSHTijgatGNTijssenJGKleijnenJ. Placebo effect in the treatment of duodenal ulcer. British Journal of Clinical Pharmacology1999; 48: 853–860
36.
MoncrieffeJWessleySHardyR. Meta-analysis of trials comparing antidepressants with active placebos. British Journal of Psychiatry1998; 172: 227–231
37.
KwanJSandercockP. In-hospital care pathways for stroke. Cochrane Database Systematic ReviewsCD002924; 2002
38.
SulchDMelbournAPerezIKalraL. Integrated care pathways and quality of life on a stroke rehabilitation unit. Stroke2002; 33: 1600–1604
39.
FalconerJARothEJSutinJAStrasserDCChangRW. The critical path method in stroke rehabilitation: lessons from an experiment in cost containment and outcome improvement. Quality Review Bulletin1993; 19: 8–16
40.
BiliaARGallonSVincieriFF. St John's Wort and depression: efficacy, safety and tolerability: an update. Life Sciences2002; 70: 3077–3096
41.
PeetMHorrobinDF. A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs. Archives of General Psychiatry2002; 59: 313–919
42.
LawlerDAHopkerSW. The effectiveness of exercise as an intervention in the management of depression: systematic review and meta-analysis of randomised controlled trials. BMJ2001; 322: 763–767
43.
GeorgeMSNahasZKozelFAGoldmanJMolloyMOliverN. Improvement of depression following transcranial magnetic stimulation. Current Psychiatry Reports1999; 1: 114–124
44.
PartonenTPartinenM. Light treatment for seasonal affective disorder: theoretical considerations and clinical implications. Acta Psychiatrica Scandinavica Supplementum1994; 377: 41–45